Literature DB >> 16345762

Isolation of Streptomyces rimosus Mutants with Reduced Actinophage Susceptibility.

M Vesligaj1, M Filipović, J Pigac, D Hranueli.   

Abstract

The infection of Streptomyces rimosus by the virulent actinophage RP1 was partially characterized. RP1 infection of the host cells results in a dramatic decrease in viable cell count, followed by reduced antibiotic production. Phage-resistant mutants were isolated after mutagenic treatment and RP1 selective pressure. Characterization of the isolated mutants has revealed that RP1 infection had no influence on their growth and antibiotic production. However, multiplication of the phage particles in the lawns of resistant mutants was detected. Since these strains differ from the wild type in RP1 relative efficiency of plating, plaque morphology, and the time necessary for plaque appearance, they are considered to be semiresistant mutants. The propagation of RP1 on semiresistant strains is characterized by lower adsorption of phage particles and longer latent and rise periods. As a consequence, the multiplication of the phage is slower than that of their host, which consequently reduces the ratio of phage to its host, thus diluting out the phage.

Entities:  

Year:  1981        PMID: 16345762      PMCID: PMC243846          DOI: 10.1128/aem.41.4.986-991.1981

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  8 in total

1.  Bacteriophage resistance in Escherichia coli K-12: general pattern of resistance.

Authors:  R E Hancock; P Reeves
Journal:  J Bacteriol       Date:  1975-03       Impact factor: 3.490

2.  The behaviour towards actinophage of mutants surviving its lytic action.

Authors:  M WELSCH
Journal:  Antonie Van Leeuwenhoek       Date:  1957       Impact factor: 2.271

3.  [Semi-resistance to bacteriophages].

Authors:  R WAHL
Journal:  Ann Inst Pasteur (Paris)       Date:  1953-01

4.  Terramycin; chemical methods of assay and identification.

Authors:  F MONASTERO; J A MEANS; T C GRENFELL; F H HEDGER
Journal:  J Am Pharm Assoc Am Pharm Assoc       Date:  1951-05

5.  Observations on the multiplication of phages affecting Streptomyces griseus.

Authors:  W L KOERBER; G GREENSPAN; A F LANGLYKKE
Journal:  J Bacteriol       Date:  1950-07       Impact factor: 3.490

6.  Characterization and persistence of actinophage RP2 isolated from Streptomyces rimosus ATCC 10970.

Authors:  D Hranueli; J Pigac; M Vesligaj
Journal:  J Gen Microbiol       Date:  1979-10

7.  Mutangenesis by N-methyl-N'-nitro-N-nitrosoguanidine (NTG) in Streptomyces coelicolor.

Authors:  V Delić; D A Hopwood; E J Friend
Journal:  Mutat Res       Date:  1970-02       Impact factor: 2.433

8.  Mutants of Escherichia coli variably resistant to bacteriophage T1.

Authors:  G R Carta; V Bryson
Journal:  J Bacteriol       Date:  1966-10       Impact factor: 3.490

  8 in total
  3 in total

1.  Optimal Cultural and Physiological Conditions for Handling Streptomyces rimosus Protoplasts.

Authors:  J Pigac; D Hranueli; T Smokvina; M Alacević
Journal:  Appl Environ Microbiol       Date:  1982-11       Impact factor: 4.792

Review 2.  Genetics of Streptomyces rimosus, the oxytetracycline producer.

Authors:  Hrvoje Petković; John Cullum; Daslav Hranueli; Iain S Hunter; Natasa Perić-Concha; Jasenka Pigac; Arinthip Thamchaipenet; Dusica Vujaklija; Paul F Long
Journal:  Microbiol Mol Biol Rev       Date:  2006-09       Impact factor: 11.056

Review 3.  Decoding and engineering tetracycline biosynthesis.

Authors:  Lauren B Pickens; Yi Tang
Journal:  Metab Eng       Date:  2008-10-22       Impact factor: 9.783

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.